2020 annual financial data
Silence Therapeutics 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -196.68%.
Operating income was -35,847,000 GBP and net income was -32,547,000 GBP.
Operating cash flow was -10,776,000 GBP.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,479,000 GBP
- Operating income
- -35,847,000 GBP
- Net income
- -32,547,000 GBP
- Operating cash flow
- -10,776,000 GBP